Supporting our data however, an increase in airway CD8+ T cells following allergen challenge predicts annual FEV1 decline in asthmatic patients [66, 67] and increased numbers can be found in patients following a fatal asthma attack [68, 69]. The gene discussed is CD8A; the disease is asthma.